Stock comparison
IDEXX Laboratories
Sotera Health
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
IDXX
IDEXX Laboratories
Market cap
$42.11B
Sector
Healthcare
SHC
Sotera Health
Market cap
$4.35B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | IDXX | SHC | Winner |
|---|---|---|---|
| Warren Buffett | 67B | 51C | IDXX |
| Benjamin Graham | 72B | 78B | SHC |
| Philip Fisher | 67B | 47D | IDXX |
| Peter Lynch | 63C | 30F | IDXX |
| Joel Greenblatt | 75B | 24F | IDXX |
| Charlie Munger | 79B | 54C | IDXX |
| Terry Smith | 76B | 52C | IDXX |
Side-by-side metrics
| Metric | IDXX | SHC |
|---|---|---|
| Market cap | $42.11B | $4.35B |
| P/E (TTM) | 39.0x | 36.9x |
| EV/EBIT | 31.6x | 16.1x |
| ROIC (TTM) | 40.66% | 7.96% |
| Gross margin | 62.05% | 55.01% |
| Net margin | 24.63% | 9.91% |
| Revenue CAGR 5y | 7.56% | 5.72% |
| EPS CAGR 5y | 10.79% | -9.92% |
| Debt / Equity | 0.7x | 3.6x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IDXX leads on
- EPS CAGR 5y10.79%vs -9.92%+192%
- Market cap$42.11Bvs $4.35B+90%
- Debt / Equity0.7xvs 3.6x+81%
- ROIC (TTM)40.66%vs 7.96%+80%
SHC leads on
- EV/EBIT16.1xvs 31.6x+49%
- P/E (TTM)36.9xvs 39.0x+5%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.